Outcomes of Gemcitabine, Vinorelbine, and Doxorubicin in Peripheral T-Cell Lymphoma. (2024). Archives of Clinical and Medical Case Reports, 8(3), 92-96. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22941